Exelixis
The DMPK Director develops and implements DMPK and modeling strategies to advance drug candidates from discovery through development, building comprehensive packages for successful drug registration. This role provides strategic and technical subject matter expertise for multiple programs within the company's portfolio. The position involves leading IND- and NDA-enabling ADME work, analyzing preclinical data, and collaborating with cross-functional teams to support drug development decisions.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
12% below the average for this role
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago